HIDDEN2 – Hospital Deep Vein Thrombosis Detection Study in Cancer Patients Receiving Palliative Care
End of project summary
Main Messages
- UK guidelines recommend risk assessment and subsequent thromboprophylaxis for all cancer patients admitted acutely in to hospital.
- Patients receiving palliative acre are at particularly high risk of developing venous thromboembolism and theoretically should receive thromboprophylaxis.
- Data from the hospice /specialist palliative care unit population has shown a high prevalence of venous thromboembolism (28%) with no impact on symptoms or survival, suggesting thromboprophylaxis is not warranted in these patients.
- The majority of palliative care patients are admitted to hospital not hospice /specialist palliative care unit.
- It is not known whether these data are transferrable to palliative care patients admitted to hospital.
- Our research shows a very low prevalence (0.6%) of acute DVT on admission suggesting this population should be considered.
It also demonstrates that despite all being described as palliative patients, those admitted to the hospice setting are phenotypically different.
Research lead
Dr Simon Noble
Amount
£249,997
Status
Completed
Start date
1 October 2021
End date
31 December 2023
Award
Research for Patient and Public Benefit (RfPPB) Wales
Project Reference
RfPPB-20-1749(P)
UKCRC Research Activity
Aetiology
Research activity sub-code
Surveillance and distribution